Innovative lipid-lowering therapy: experience of inclisiran use in the Republic of Belarus
The article reflects modern aspects of lipid-lowering therapy, based on the assessment of cardiovascular risk, and the possibilities of triple therapy, including statins, ezetimibe, and inclisiran.We present our own data on the use of the drug inclisiran in patients with lipid metabolism disorders...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
«FIRMA «SILICEA» LLC
2023-05-01
|
| Serija: | Российский кардиологический журнал |
| Teme: | |
| Online dostop: | https://russjcardiol.elpub.ru/jour/article/view/5417 |
| Oznake: |
Brez oznak, prvi označite!
|